XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 83,391 $ 73,981
Marketable securities 17,532 22,518
Research and development tax credit receivable 2,283 2,248
Prepaid expenses and other current assets 6,264 2,096
Total current assets 109,470 100,843
Property and equipment, net 782 839
Operating lease right-of-use assets 1,475 1,713
Goodwill 16,836 16,836
Research and development tax credit receivable 1,245 1,232
Other non-current assets 10,931 11,322
Total assets 140,739 132,785
Current liabilities:    
Current portion of long-term debt 20,515 37,668
Current portion of operating lease liability 871 960
Accounts payable 10,023 7,890
Accrued expenses 7,683 7,334
Proceeds received in advance of Series B Preferred Shares issuance 40,000 0
Other current liabilities 269 1,941
Total current liabilities 79,361 55,793
Long-term debt 93,139 91,614
Long-term operating lease liability 638 780
Other non-current liabilities 5,767 5,743
Total liabilities 178,905 153,930
Shareholders’ (deficit) equity:    
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at March 31, 2023 and 488 issued and outstanding at December 31, 2022 5 5
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 64,478 issued and outstanding at March 31, 2023 and 62,878 issued and outstanding at December 31, 2022 644 628
Additional paid-in capital 603,215 589,783
Accumulated deficit (616,004) (585,220)
Accumulated other comprehensive loss (26,026) (26,341)
Total shareholders’ (deficit) equity (38,166) (21,145)
Total liabilities and shareholders’ (deficit) equity $ 140,739 $ 132,785